| CTRI Number |
CTRI/2025/04/085020 [Registered on: 17/04/2025] Trial Registered Prospectively |
| Last Modified On: |
05/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug
Homeopathy
Diagnostic
Preventive |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
This study aimed to observe difference between Ferrum Phosphoricum 6x and Natrum Muriaticum 6x in the treatment of iron deficiency anemia in 18-25 year age group females |
|
Scientific Title of Study
|
Comparative study of Ferrum Phosphoricum 6x and Natrum Muriaticum 6x in the treatment of Iron deficiency anemia of female: A Randomized Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DrPreksha Prashantbhai Labana |
| Designation |
B.H.M.S,PG (Scholar) |
| Affiliation |
Parul institute of Homoeopathic & research, |
| Address |
Parul institute of Homoeopathic & research,Parul University,Ishwarpura,
vadodara,Gujarat
Parul institute of Homoeopathic & research,Parul University,Ishwarpura,
vadodara,Gujarat
Vadodara
GUJARAT
391760
India |
| Phone |
7984460174 |
| Fax |
|
| Email |
prekshalabana66@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Mamta Tapas |
| Designation |
B.H.M.S(MD) HOD of Homoeopathic Materia Medica |
| Affiliation |
Parul institute of Homoeopathic & research, |
| Address |
Parul institute of Homoeopathic & research,Parul University,Ishwarpura,
vadodara,Gujarat
Parul institute of Homoeopathic & research,Parul University,Ishwarpura,
vadodara,Gujarat
Vadodara
GUJARAT
391760
India |
| Phone |
7984460174 |
| Fax |
|
| Email |
mamta.tapas87086@paruluniversity.ac.in |
|
Details of Contact Person
Public Query
|
| Name |
DrPreksha Prashantbhai Labana |
| Designation |
B.H.M.S,PG (Scholar) |
| Affiliation |
Parul institute of Homoeopathic & research, |
| Address |
Parul institute of Homoeopathic & research,Parul University,Ishwarpura,
vadodara,Gujarat
Parul institute of Homoeopathic & research,Parul University,Ishwarpura,
vadodara,Gujarat
GUJARAT
391760
India |
| Phone |
7984460174 |
| Fax |
|
| Email |
prekshalabana66@gmail.com |
|
|
Source of Monetary or Material Support
|
| Parul institute of Homoeopathic research & hospital,Ishwarpura,post limda Parul University, Vadodara-391760 Gujarat,India |
|
|
Primary Sponsor
|
| Name |
Dr Preksha Prashantbhai Labana |
| Address |
Parul institute of homoeopathy research and hospital,ishwarpura,vadodara-391760,Gujarat,India |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Preksha Labana |
Parul institute of homoeopathy and research hospital hospital |
101(c)Medicine opd,Parul institute of homeopathy and research hospital hospital,Parul university,vadodara
Vadodara
GUJARAT |
7984460174
prekshalabana66@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, PIHR IECHR |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: D509||Iron deficiency anemia, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Ferrum phosphoricum 6x(biochemic medicine) 3 tab two times a day
for 1 month |
Ferrum phosphoricum 6x(biochemic medicine) 3 tab BD given for 6 months ,for hemoglobin assesement cbc investigation will be done after prescribing medicine on 3rd month and 6 months.after 6 months overall assesement will be done. |
| Comparator Agent |
Natrum Muriaticum 6x(biochemic medicine)3tab two times a day for 1 month |
Natrum Muriaticum6x(biochemic medicine) 3 tab BD given for 6 months ,for hemoglobin assesement cbc investigation will be done after prescribing medicine on 3rd month and 6 months.after 6 months overall assesement will be done |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
25.00 Year(s) |
| Gender |
Female |
| Details |
Gender-female only
Age-between age group of 18-25 year collage going girls.
Female having low hemoglobin more than 8% to less than 12% with low MCV and low MCH cases should be taken.
Female who have started their menarche and having regular menstrual cycle. |
|
| ExclusionCriteria |
| Details |
Female having low hemoglobin with normal MCV and MCH volume should be excluded.
Pregnant and lactating women
Female having any menstrual disorder, genetic disorder, systemic disorder, or suffering from any chronic illness was excluded. |
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| â—To compare the difference of hemoglobin with MCV and MCH volume after giving the Ferrum phosphoricum 6x and Natrum muriaticum 6x in different group of 18-25 year females within study time period. |
12 month,
per patient 1 month for symptoms wise,cbc in 3 month,6th month. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| â—To evaluate the efficacy and effectiveness of Ferrum phosphoricum 6x and Natrum muriaticum 6x with improvement of other clinical sign and symptoms of iron deficiency anemia in adult age group of girls. |
12 month,
per patient 1 month for symptoms wise,cbc in 3 month,6th month. |
|
|
Target Sample Size
|
Total Sample Size="30"
Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
30/04/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1"
Months="0"
Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
A randomized controlled trial assessed the benefits of Ferrum Phosphoricum 6x and Natrum Muriaticum 6x in treating iron deficiency anemia among females aged 18-25, highlighting the potential of homeopathic treatments in managing this condition. The study aimed to compare the efficacy of these two homeopathic remedies, focusing on improvements in hemoglobin levels, anemia symptoms, and overall well-being.
Ferrum Phosphoricum 6x, known for its role in enhancing oxygenation and supporting iron absorption, was found to be particularly effective in increasing hemoglobin levels and addressing fatigue and weakness. Natrum Muriaticum 6x, often used to balance electrolytes and support fluid distribution, showed additional benefits in managing symptoms like low energy, mood swings, and dehydration commonly associated with anemia.
The study concluded that both remedies positively impacted young women with iron deficiency anemia. Ferrum Phosphoricum 6x was more directly effective for improving iron levels, while Natrum Muriaticum 6x provided a broader range of symptom relief, contributing to overall vitality and energy. The trial demonstrated that homeopathic treatment could be a supportive and gentle approach to managing iron deficiency anemia, offering specific benefits aligned with individual symptoms. |